ArticleInternational journal of retina and vitreous2026
C3a and C5a plasma concentrations in patients with diabetic retinopathy: a cross-sectional study.
Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High Glucose Induces Biomolecular Dysregulation in Primary Human Corneal Epithelial Cells: Potential Biomarkers of Hyperglycemia-Driven Corneal Impairment.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic retinopathy (DR) is the leading cause of irreversible blindness in adults, with inflammation playing a critical role in its pathogenesis, particularly involving the complement system (CS). Components of the complement cascade, such as C3a and C5a, have been identified in both vitreous and plasma samples from individuals with DR. This study aimed to evaluate plasma concentrations of C3a and C5a in relation to DR onset and severity.
methodsA total of 150 patients with diabetes mellitus (DM) underwent ophthalmic examination and were categorized into groups: without DR (control group), mild/moderate/severe non-proliferative DR (NPDR) and proliferative DR (PDR). Plasma C3a and C5a levels were measured using sandwich enzyme-linked immunosorbent assays (ELISA).
resultsSignificant elevations in C3a levels were found in severe NPDR (p = 0.02) and PDR (p < 0.05) groups compared to controls. Furthermore, severe/proliferative DR exhibited higher C3a levels than mild/moderate NPDR (p = 0.015). No significant differences in C5a concentrations were observed among the groups.
conclusionThese findings suggest the involvement of complement in the pathogenesis of DR, and the association of C3a with DR severity highlights its potential as a prognostic biomarker and therapeutic target.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.